18PH002 - Procrastinator's Marathon 2017: Updates on New Drugs; Opioid Crisis

Dec 10, 2017 Pharmacy

18PH002 - Procrastinator's Marathon 2017: Updates on New Drugs; Opioid Crisis

Description

Now’s your last chance to obtain live 2017 continuing educational credits for pharmacy license renewal!!

Attend live in person or via GoToWebinar!

This knowledge-based continuing education program and webinar will update the participant about office based opioid treatment in a primary care setting; the newest drugs to enter the market in 2017; the landscape of multi-drug resistant organisms (MDRO); a review of Non-Insulin injectibles for Type 2 Diabetes; and an evaluation of the 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines . You don’t want to miss out on this relevant information.

Target Audience

Pharmacists and Pharmacy Technicians in all aspects of pharmacy

Objectives

  • Pharmacists/Pharmacy Technicians: Define OBOT and how it can be delivered
  • Pharmacists/Pharmacy Technicians: List at least 10 medications that were newly approved by the FDA in the past year that are or may be prescribed from their practice site
  • Pharmacists/Pharmacy Technicians: Review the mechaism of action of these medications and their role in their respective disease states
  • Pharmacists/Pharmacy Technicians: Briefly discuss literature regarding the newly FDA approved therapies
  • Pharmacists/Pharmacy Technicians: Demonstrate proper administration technique and patient counseling for non-insulin injectible products
  • Pharmacists/Pharmacy Technicians: Recognize patient criteria for the diagnosis of COPD
  • Pharmacists/Pharmacy Technicians: Classify patients with COPD into their designated treatment groups
  • Pharmacists/Pharmacy Technicians: Demonstrate proper inhaler use technique for various treatment delivery systems
  • Pharmacy Technicians: Identify patients at risk for MDRO based upon medications and history
  • Pharmacy Technicians: Describe ways to assist in antimicrobial stewardship efforts
  • Pharmacists: Identify key differences between buprenorphine and methadone
  • Pharmacists: Discuss how pharmacists can be part of buprenorphine team based care
  • Pharmacists: Describe the dosing, precautions, common side effects, and key patient counseling points for these medications
  • Pharmacists: Apply conclusions drawn from literature to clinical practice
  • Pharmacists: Discuss treatment options and guideline-based recommendations for S.pneumoniae, S.aureus, P.aeruginosa, and E.coli infections
  • Pharmacists: Review national and local resistance patterns for S.pneumoniae,S. aureus, P.aeruginosa, and E.coli
  • Pharmacists: Discuss future drug research and direction on combating S.pneumoniae, S.aureus, P.aeruginosa, and E.coli infections
  • Pharmacists: Summarize the mechanism of action and place in therapy of GLP-1 RAs
  • Pharmacists: Analyze the basal insulin and GLP-1 RA combination products insulin degludec & liraglutide and insulin glargine and lixisenatide
  • Pharmacists: Develop an appropriate pharmacolgic treatment plan for a patient with COPD based on their treatment group

Sessions

Morning Session Options

Procrastinator's Marathon 2017: Updates on New Drugs; Opioid Crisis (MORNING SESSION) - LIVE at MAHEC Education
12/10 8:30 AM–11:45 AM
Procrastinator's Marathon 2017: Updates on New Drugs; Opioid Crisis (MORNING SESSION) - Go to Webinar
12/10 8:30 AM–11:45 AM
I will not be attending the morning session.
12/10 8:30 AM–11:45 AM

Afternoon Session Options

Procrastintor's Marathon 2017: Updates on New Drugs; Opioid Crisis (AFTERNOON SESSION) - LIVE at MAHEC Education
12/10 12:45 PM–4:00 PM
Procrastinator's Marathon 2017: Updates on New Drugs; Opioid Crisis (AFTERNOON SESSION) - Go to Webinar
12/10 12:45 PM–4:00 PM
I will not be attending the afternoon session
12/10 12:45 PM–4:00 PM

Credits

.300 CEU

Morning Session

.300 CEU

Afternoon Session

3.000 ACPE

Afternoon Session

3.000 ACPE

Morning Session

Fees

Brochure PDF